Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 1/20 | 0.48 |
| ▸ | SARM1 | Q6SZW1 | 1/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.48 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
| ▸ | SIRT4 | Q9Y6E7 | 1/20 | 0.48 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CDK4 | P11802 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | CCND1 | P24385 | 1/20 | 0.40 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.38 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Niacinamide SCHEMBL28184048 | 1.00 | F7 (0.48) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL3915026 | 0.92 | F7 (0.44) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL28671370 | 0.92 | F7 (0.46) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL3907994 | 0.90 | F7 (0.42) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL20398298 | 0.89 | F7 (0.55) | F7F3SARM1SIRT2SIRT6 | |
| Benzamide SCHEMBL4301755 | 0.86 | MAOB (0.46) | POLBMAOB | |
| Niacinamide SCHEMBL28136690 | 0.85 | F7 (0.51) | F7F3SARM1SIRT2SIRT6 | |
| Ribose (Furanose) SCHEMBL17315030 | 0.85 | F7 (0.54) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL17315028 | 0.84 | F7 (0.50) | F7F3SARM1SIRT2SIRT6 | |
| Niacinamide SCHEMBL21571784 | 0.84 | F7 (0.50) | F7F3SARM1SIRT2SIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119789865-A | ROR1/EGFR bispecific antigen binding molecules | 阿尔麦克探索有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-114929738-B | Anti-NAMPT antibodies and uses thereof | 水肺治疗公司 | 2026-01-02 | — | — | CN | disclosed |
| CN-119789865-A | ROR1/EGFR bispecific antigen binding molecules | 阿尔麦克探索有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-116440280-B | Multi-target-point-based anti-breast cancer pharmaceutical composition and application thereof | 江苏大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-106659766-B | Enolase 1 (ENO 1) compositions and uses thereof | 博格有限责任公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-114566231-B | Drug inhibition efficacy strength prediction method based on small data set | 汕头市翼送软件有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-117510484-B | MIDH1/NAMPT double-target inhibitor and application thereof | 中国药科大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118995669-A | Ultra-small volume gene editing system and application thereof in construction of cell factories | 浙江工业大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-118434765-A | BCMA monoclonal antibodies and antibody-drug conjugates | 杭州多禧生物科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-112654608-B | Fused ring compound having urea structure | 桑福德伯纳姆普利斯医学发现研究所 | 2024-05-07 | — | — | CN | disclosed |
| CN-117679441-A | Application of exosomes derived from mesenchymal stem cells in preparation of medicines for preventing and/or treating arterial hemangioma | 广东省人民医院 | 2024-03-12 | — | — | CN | disclosed |
| CN-110945128-B | Compositions and methods for treating pulmonary fibrosis | 代表亚利桑那大学的亚利桑那董事会 | 2023-11-03 | — | — | CN | disclosed |
| CN-116440280-A | Multi-target-point-based anti-breast cancer pharmaceutical composition and application thereof | 江苏大学 | 2023-07-18 | — | — | CN | disclosed |